IMIDomics Inc. Alternatives & Competitors

12 companies similar to IMIDomics Inc. — Discovering and developing the next generation of medicines for immune-mediated...

VBL Therapeutics (Nasdaq:VBLT)

Engineering the future of targeted medicines, breaking barriers to develop the next genera...

15 Post-IPO Equity $62.76M

Israel

Biotechnology Health Care +1

Forma Therapeutics

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...

159 Series D $142.50M

Watertown, United States

Biotechnology Health Care +1

Cipherome, Inc

AI-driven data analysis platform enhancing healthcare research with predictive analytics,...

12 Series B $19.50B

San Jose, United States

Biopharma Biotechnology +1

Biognosys

Transforming life sciences with cutting-edge proteomics technology and solutions

90 Series G $9.03M

Schlieren, Switzerland

Biotechnology Health Care

Track all IMIDomics Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Alumis

Transforming the lives of patients living with immune-mediated diseases using a precision...

249 Series C $529.00M

South San Francisco, Unit...

Biotechnology Health Care +1

ROME Therapeutics

Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...

16 Acquired $199.00M

Boston, United States

Biotechnology Health Care +1

LYNK Pharmaceuticals

Pioneering novel treatments for oncology, immunology, and inflammatory diseases since 2018...

11-50 Series C $402.00M

Biotechnology Health Care +1

ACEA Therapeutics, Inc

Committed to improving the lives of patients with chronic and life-threatening diseases.

San Diego, United States

Biotechnology Health Care +1

Scipher Medicine

Scipher Medicine is a precision immunology company matching each patient with their most e...

87 Series D $227.00M

Waltham, United States

Biotechnology Health Care

Denovo Biopharma

29 Grant $1.20B

San Diego, United States

Biopharma Biotechnology +1

Compare

LinusBio

Precision Exposome Medicine

35 $47.65M

North Brunswick, United S...

Biotechnology Health Care +1

Evelo Biosciences

Clinical stage biotech company developing a new modality of oral biologics that act on cel...

22 Post-IPO Equity $397.00M

Cambridge, United States

Biotechnology Health Care +1

About IMIDomics Inc.

IMIDomics Inc. is a biotechnology startup with the slogan "Discovering and developing the next generation of medicines for immune-mediated inflammatory diseases (IMIDs)." Founded in 2015, the company is headquartered in the United States and operates within the Biotechnology and Health Care industries. IMIDomics focuse...

Taxonomy

Immunology, Drug Discovery, Inflammatory Diseases, Clinical Research, Biomolecular Datasets, Patient-centric, Biobank, Genomic Analysis, Genetic Analysis, Bioinformatics, Clinical Expertise, Targeted Therapy, Vall D’Hebron Institute Of Research

Frequently Asked Questions

Companies similar to IMIDomics Inc. include VBL Therapeutics (Nasdaq:VBLT), Forma Therapeutics, Cipherome, Inc, Biognosys, Alumis. They work in Biotechnology and Health Care and share IMIDomics Inc.'s focus on immunology, drug discovery and inflammatory diseases.

Bounce Watch lists 12 companies that share IMIDomics Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches IMIDomics Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

IMIDomics Inc. Profile Cipherome, Inc Alternatives Biognosys Alternatives Alumis Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at IMIDomics Inc. on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.